An HIV vaccine may have the purpose of protecting individuals who do not have HIV from being infected with the virus (a preventative vaccine), or treating an HIV-infected person (a therapeutic vaccine). There are two approaches to an HIV vaccine: an active vaccination approach in which a vaccine aims to induce an immune response against HIV; and a passive vaccination approach in which preformed antibodies against HIV are administered.
The report focuses on the Hiv Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Hiv Vaccine market.
Major Players in the Hiv Vaccine market are:
Sanofi
GeoVax Labs
Genetic Immunity
GeneCure
AlphaVax
GenVec
Novartis
Argo Therapeutics
Immune Response BioPharma
Antigen Express
FIT Biotech
Inovio Pharmaceuticals
Crucell Pharmaceutical
Bionor Pharmaceuticals
Oncolys Biopharma
Celldex Therapeutics
PaxVax
Profectus Biosciences
Glaxo Smithkline
TVAX Biomedical
On the basis of types, the Hiv Vaccine market is primarily split into:
Therapeutic Vaccine
Preventive Vaccine
On the basis of applications, the market covers:
Infants
Early Aged
Post Aged
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Hiv Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Hiv Vaccine Market Overview
1.1 Product Overview and Scope of Hiv Vaccine Market
1.2 Hiv Vaccine Market Segment by Type
1.2.1 Global Hiv Vaccine Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Hiv Vaccine Market Segment by Application
1.3.1 Hiv Vaccine Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Hiv Vaccine Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Hiv Vaccine (2017-2029)
1.5.1 Global Hiv Vaccine Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Hiv Vaccine Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Hiv Vaccine Industry
1.7 Impact of Carbon Neutrality on the Hiv Vaccine Industry
2 Hiv Vaccine Market Upstream and Downstream Analysis
2.1 Hiv Vaccine Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Hiv Vaccine Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Sanofi
3.1.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Hiv Vaccine Market Performance (2017-2022)
3.1.4 Business Overview
3.2 GeoVax Labs
3.2.1 GeoVax Labs Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Hiv Vaccine Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Genetic Immunity
3.3.1 Genetic Immunity Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Hiv Vaccine Market Performance (2017-2022)
3.3.4 Business Overview
3.4 GeneCure
3.4.1 GeneCure Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Hiv Vaccine Market Performance (2017-2022)
3.4.4 Business Overview
3.5 AlphaVax
3.5.1 AlphaVax Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Hiv Vaccine Market Performance (2017-2022)
3.5.4 Business Overview
3.6 GenVec
3.6.1 GenVec Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Hiv Vaccine Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Novartis
3.7.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Hiv Vaccine Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Argo Therapeutics
3.8.1 Argo Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Hiv Vaccine Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Immune Response BioPharma
3.9.1 Immune Response BioPharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Hiv Vaccine Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Antigen Express
3.10.1 Antigen Express Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Hiv Vaccine Market Performance (2017-2022)
3.10.4 Business Overview
3.11 FIT Biotech
3.11.1 FIT Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Hiv Vaccine Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Inovio Pharmaceuticals
3.12.1 Inovio Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Hiv Vaccine Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Crucell Pharmaceutical
3.13.1 Crucell Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Hiv Vaccine Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Bionor Pharmaceuticals
3.14.1 Bionor Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Hiv Vaccine Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Oncolys Biopharma
3.15.1 Oncolys Biopharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Hiv Vaccine Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Celldex Therapeutics
3.16.1 Celldex Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Hiv Vaccine Market Performance (2017-2022)
3.16.4 Business Overview
3.17 PaxVax
3.17.1 PaxVax Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Hiv Vaccine Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Profectus Biosciences
3.18.1 Profectus Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Hiv Vaccine Market Performance (2017-2022)
3.18.4 Business Overview
3.19 Glaxo Smithkline
3.19.1 Glaxo Smithkline Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Hiv Vaccine Market Performance (2017-2022)
3.19.4 Business Overview
3.20 TVAX Biomedical
3.20.1 TVAX Biomedical Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 Hiv Vaccine Market Performance (2017-2022)
3.20.4 Business Overview
4 Global Hiv Vaccine Market Landscape by Player
4.1 Global Hiv Vaccine Sales and Share by Player (2017-2022)
4.2 Global Hiv Vaccine Revenue and Market Share by Player (2017-2022)
4.3 Global Hiv Vaccine Average Price by Player (2017-2022)
4.4 Global Hiv Vaccine Gross Margin by Player (2017-2022)
4.5 Hiv Vaccine Market Competitive Situation and Trends
4.5.1 Hiv Vaccine Market Concentration Rate
4.5.2 Hiv Vaccine Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Hiv Vaccine Sales, Revenue, Price Trend by Type
5.1 Global Hiv Vaccine Sales and Market Share by Type (2017-2022)
5.2 Global Hiv Vaccine Revenue and Market Share by Type (2017-2022)
5.3 Global Hiv Vaccine Price by Type (2017-2022)
5.4 Global Hiv Vaccine Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Hiv Vaccine Sales, Revenue and Growth Rate of Therapeutic Vaccine (2017-2022)
5.4.2 Global Hiv Vaccine Sales, Revenue and Growth Rate of Preventive Vaccine (2017-2022)
6 Global Hiv Vaccine Market Analysis by Application
6.1 Global Hiv Vaccine Consumption and Market Share by Application (2017-2022)
6.2 Global Hiv Vaccine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Hiv Vaccine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Hiv Vaccine Consumption and Growth Rate of Infants (2017-2022)
6.3.2 Global Hiv Vaccine Consumption and Growth Rate of Early Aged (2017-2022)
6.3.3 Global Hiv Vaccine Consumption and Growth Rate of Post Aged (2017-2022)
7 Global Hiv Vaccine Sales and Revenue Region Wise (2017-2022)
7.1 Global Hiv Vaccine Sales and Market Share, Region Wise (2017-2022)
7.2 Global Hiv Vaccine Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Hiv Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Hiv Vaccine Market Forecast (2022-2029)
8.1 Global Hiv Vaccine Sales, Revenue Forecast (2022-2029)
8.1.1 Global Hiv Vaccine Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Hiv Vaccine Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Hiv Vaccine Price and Trend Forecast (2022-2029)
8.2 Global Hiv Vaccine Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Hiv Vaccine Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Hiv Vaccine Sales and Revenue Forecast (2022-2029)
8.2.3 China Hiv Vaccine Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Hiv Vaccine Sales and Revenue Forecast (2022-2029)
8.2.5 India Hiv Vaccine Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Hiv Vaccine Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Hiv Vaccine Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Hiv Vaccine Sales and Revenue Forecast (2022-2029)
8.3 Global Hiv Vaccine Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Hiv Vaccine Revenue and Growth Rate of Therapeutic Vaccine (2022-2029)
8.3.2 Global Hiv Vaccine Revenue and Growth Rate of Preventive Vaccine (2022-2029)
8.4 Global Hiv Vaccine Consumption Forecast by Application (2022-2029)
8.4.1 Global Hiv Vaccine Consumption Value and Growth Rate of Infants (2022-2029)
8.4.2 Global Hiv Vaccine Consumption Value and Growth Rate of Early Aged (2022-2029)
8.4.3 Global Hiv Vaccine Consumption Value and Growth Rate of Post Aged (2022-2029)
8.5 Hiv Vaccine Market Forecast Under COVID-19
9 Industry Outlook
9.1 Hiv Vaccine Market Drivers Analysis
9.2 Hiv Vaccine Market Restraints and Challenges
9.3 Hiv Vaccine Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Hiv Vaccine Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Hiv Vaccine Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Hiv Vaccine Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Abacavir Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 106
Market Overview of Global Abacavir market:
According to our latest research, the global Abacavir market looks promising in the next 5 years. As of 2022, the global Abacavir market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir market, with a systematical descriptio......
Global Abacavir Market Research Report 2023
Published: 05-Dec-2023 Price: US 2900 Onwards Pages: 85
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Abacavir market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- GSK
- Aurobindo
- Novnauki
- Smilax
- Hycultec
- Atripla
Segment by Type
- Tablet Abacavir
- Oral Solution Abacavir
S......
Global Zidovudine Market Research Report 2023, Forecast to 2028
Published: 22-Nov-2023 Price: US 2680 Onwards Pages: 136
Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......
Global Zidovudine Professional Survey Report 2023, Forecast to 2028
Published: 22-Nov-2023 Price: US 3280 Onwards Pages: 104
Zidovudine is used along with other medications to treat human immunodeficiency virus (HIV) infection. Zidovudine is given to HIV-positive pregnant women to reduce the chance of passing the infection to the baby. Zidovudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (m......
Global Abacavir Sulfate Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 29-Aug-2023 Price: US 3380 Onwards Pages: 127
Market Overview of Global Abacavir Sulfate market:
According to our latest research, the global Abacavir Sulfate market looks promising in the next 5 years. As of 2022, the global Abacavir Sulfate market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Abacavir Sulfate market......
Global Zidovudine Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 75
Zidovudine (ZDV), also known as azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein.
The global Zidovudin......
Global HIV Drugs Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 93
HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.
The global HIV Drugs market is projected to grow from US$ 23910 million in 2023 to US$ 26950 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.......
HIV Treatment Drugs Industry Forecasts - China Focus
Published: 24-Jul-2023 Price: US 1800 Onwards Pages: 91
This study focuses on China's HIV Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
HIV Treatment Drugs Markets in China
Published: 24-Jul-2023 Price: US 4000 Onwards Pages: 225
China's demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ind......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
